Psoriasis
Conditions
Interventions
Experimental Group:1. Basic treatment (strengthening emollient and moisturising
reasonable bathing and cleaning of skin
avoiding triggering and aggravating factors
reasonable life and living
adhering to reasonable treatment)
2. Si Cao cream applied externally to the affected area twice a day for a total course of 8 weeks.
Control Group:1. Basic treatment (strengthening emollient and moisturising
2. calcipotriol applied externally to the affected area twice a day for a total course of 8 weeks.
Sponsors
Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. It meets the western medical diagnostic criteria for psoriasis of the common type; 2 Skin lesions body surface area (BSA) <10% or PASI <10 points; 3. 18 years = age = 65 years gender is not limited; 4. Those who agreed to participate in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. A history of intolerance to topical vitamin D3 derivatives or herbal topical treatments; 2. Other active skin diseases that may affect the assessment of the disease; 3. Previous treatment with etanercept infliximab ezekizumab adalimumab guselchizumab ustekinumab and skuticumab and discontinuation of the treatment = 14 40 52 64 72 days respectively 84 days and 108 days. Or have been treated with JAK inhibitors and the withdrawal time is =1 week; 4. Have received topical glucocorticoids phototherapy etc. within 2 weeks; 5. Are in the period of severe uncontrollable local or systemic acute or chronic infections; 6. Have a history of malignant tumours and patients with primary or secondary immunodeficiencies and hypersensitivity; 7. Are pregnant or breastfeeding women; 8. Have a history of alcohol drug or substance abuse; 9. Have a history or family history of severe psychiatric illness; 10. History or family history of severe mental illness; 10. Other reasons the investigator considers inappropriate for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| relapse rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment efficacy rate;Psoriasis Area and Severity Index(PASI);Visual analogue scale (VAS);Time of relapse;Dermatology Life Quality Index (DLQI); | — |
Countries
China
Contacts
Public ContactBin Li
Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Outcome results
None listed